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Several herbal preparations are used to treat diabetes, but their reported hypoglycemic effects are 
complex. This study therefore was designed to evaluate the effect of aqueous extract of Vitex doniana 
leaves on oxidative stress and lipid peroxidation in streptozotocin-induced diabetic and non-diabetic 
rats. Diabetes was induced intraperitoneally using 50 mg/kg streptozotocin, while diabetic rats were 
treated in 12 h cycles for four weeks with 100 mg/kg of the extract and glibenclamide (2.5 mg/kg). 
Nondiabetic control rats received distilled water. The levels of fasting blood sugar (FBS), thiobarbituric 
acid reactive substance (TBARS), aspartatate aminotransfrease (AST), alanine aminotransferase (ALT), 
alkaline phosphatase (ALP), catalase (CAT) and superoxide dismutase (SOD) activities total, conjugated 
and unconjugated bilirubin concentration were assayed. The results indicate that the concentrations of 
TBARS, ALT, AST, ALP and bilirubin were significantly increased while the activities of SOD and CAT 
were reduced in the diabetic animals (p<0.05). The extract significantly increased CAT and SOD activity 
and reduced FBS, TBARS, ALT, AST, ALP and bilirubin concentrations significantly (p<0.05) compared 
to normal. However, glibenclamide treatment showed slight modification in the changes observed 
compared to the extract. The study concluded that the extract reversed diabetes and diabetes-induced 
oxidative changes in the hepatocytes, thus suggesting its use for the management of diabetic 
complications. 
 





Diabetes mellitus is a chronic metabolic disorder 
characterize by degeneration of carbohydrates, protein 
and fat metabolism (O’Brien and Granner, 1996). Such 
alterations result in increased blood glucose, which 
causes long-term complications in many organs. 
Oxidative stress in cells and tissues results from the 
increased generation of reactive oxygen species and/or 
from diseases in antioxidant defense potential 
(Gumieniczek et al., 2002). Lipid peroxidation of cellular 
structures, a consequence of free radical activity in turn
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seemed to play an important role in aging and late 
complications of diabetes (Ugochukwu and Cobourne, 
2003; Hunkar et al., 2002) disrupting natural antioxidant 
defence systems and altering antioxidant enzyme 
activities in various tissues like the liver (Rauscher et al., 
2000; Rauscher et al., 2001). On the other hand, an 
increase in circulating lipids may be a reason for 
increased lipid peroxidation in diabetes. Currently, there 
is a renewed and growing interest in the use of plant-
based products as drugs or as ‘leads’ in the manufacture 
of more potent drugs (Ogbonnia et al., 2008). Several 
secondary plant metabolites have been shown to modify 
biological processes, which may reduce the risk of 
chronic diseases in humans (Ugochukwu et al., 2003). 
Globally, the prevalence of diabetes mellitus is 
increasing. The increase in prevalence has accelerated 
due to the aging population structure in the developed 
countries and due to the globally increasing obesity, as 
well as stressing life style. 
Diabetes mellitus is the sixth leading cause of death 
globally (Nash et al., 2001). Vitex doniana sweet, (family 
Verbanaceae) is a perennial shrub widely distributed in 
tropical West Africa, and some East African countries 
including Uganda, Kenya and Tanzania, and high rainfall 
areas. It is found in the middle belt of Nigeria particularly 
Kogi, Benue, and parts of the savannah regions of 
Kaduna, Sokoto and Kano states (Etta, 1984). It is 
variously called vitex (English), dinya (Hausa), dinchi 
(Gbagyi), uchakoro (Igbo), oriri (Yoruba) ejiji (Igala) and 
olih (Etsako) (Burkill, 2000). V. doniana is employed in 
the treatment of a variety of diseases. Hot aqueous 
extracts of the leaves are used in the treatment of 
stomach and rheumatic pains, inflammatory disorders, 
diarrhoea dysentery and diabetes (Irvine, 1961; Etta, 
1984) indicating that the plant’s leaves may possess 
antidaibetic properties among others. The roots and 
leaves are used for nausea, colic and epilepsy (Bouquet 
et al., 1971; Iwu, 1993). In North-Central and eastern 
parts of Nigeria, the young leaves are used as vegetables 




MATERIALS AND METHODS 
 
Collection and preparation of plant materials 
 
Fresh leaves of V. doniana were collected from its natural habitat in 
Ankpa, Kogi State, and it was identified and authenticated by the 
ethnobotanist in the Department of Medicinal Plant Research and 
Traditional Medicine of the National Institute for Pharmaceutical 
Research and Development (NIPRD), Abuja, Nigeria. A voucher 
specimen number NIPRD/H/6415 was deposited at the herbarium 
of the department. The plant material was dried in the laboratory at 











water (1:5 W/V) and was allowed to stand for 24 h at room 
temperature. The extract was filtered and the filtrate was 
concentrated using rotary evaporator under reduced pressure. It 
was allowed to dry at room temperature and stored in refrigerator 
prior to usage. 
 
 
Ethanol / n-hexane extraction 
 
About 400 g of the pulverized sample was soaked in 2 L (1:5 w/v) of 
ethanol/n-hexane (2:1 v/v) for 24 h. The extract was filtered under 
reduced pressure using filter paper, membrane filter and vacuum 
pump. Ethanol extract was separated from the n-hexane extract 
using separatory funnel and the filtrates were concentrated using 
rotary evaporator under reduced pressure respectively. The 
extracts were reconstituted freshly in distilled water at appropriate 
concentrations for the various experimental doses using the 
equation of Tedong et al. (2007): 
 
V(ml) = (D × P)/C 
 
Where D = dose used (g/kg body weight); P = body weight (g); C = 





Male albino rats (7 to 8 weeks old) were purchased from the animal 
house of the Department of Biosciences, Salem University, Lokoja, 
Nigeria. They were acclimatized for two weeks prior to 
commencement of experiment. They were kept at room 
temperature and maintained ad libitum on growers mash (feed) and 
weighed prior to experiment. 
 
 
Induction of diabetes 
 
Rats were fasted overnight and experimental diabetes was induced 
by intraperitoneal injection of streptozotocin (STZ) with a single 
dose of 50 mg/kg body weight. STZ was dissolved in a freshly 
prepared 0.1 M cold citrate buffer of pH 4.5 (Rakieten et al., 1963). 
Control rats were similarly injected with citrate buffer. Because STZ 
is capable of inducing fatal hypoglycemia as a result of massive 
pancreatic insulin release, STZ treated rats were provided with 10% 
glucose solution after 6 h for the next 24 h to prevent severe 
hypoglycemia. After 3 days for development and aggravation of 
diabetes, rats with moderate diabetes (that is, blood glucose 
concentration 250 mg/dl) that exhibited hyperglycemia were 





In the experiment, the rats were divided into nine groups of five rats 
each and treatment was carried out orally. Group 1: (N. control) 
normal rats (non-diabetic, no treatment); Group 2: (D. control) 
diabetic rats, no treatment; Group 3: (D. STD) diabetic rats treated 
with 2.5 mg/kg glibenclamide; Group 4: (D. aqueous) diabetic rats 
treated with 100 mg/kg aqueous extract; Group 5: (D. ethanol) 
diabetic rats treated with 100 mg/kg of the ethanol extract; Group 6: 
(D. hexane) diabetic rats treated with 100 mg/kg of the n-hexane 
extract; Group 7: (N. aqueous) non-diabetic rats treated with 100 
mg/kg aqueous extract; Group 8: (N. ethanol) non-diabetic rats 
treated with 100 mg/kg of ethanol extract; 
Group 9: (N. hexane) non-diabetic rats treated with 100 mg/kg of n-
hexane extract. 
On the 28th day of post-treatment, the animals were fasted 





decapitation. Blood was collected in centrifuge tubes, and serum 
collected after centrifugation at 2,000rpm for 10 min and stored in 
deep-freezer prior to analysis. Fasting blood glucose and packed 
cell volume was monitored weekly. Liver and kidneys were 
surgically removed, immediately washed with ice-cold normal saline 





Weighed liver and kidney samples were homogenised separately in 
10 parts (w/v) of ice-cold 50 mM Tris-HCl, (pH 7.4) using a 
homogeniser (Janke and Kunkel, Germany). The homogenates 
were centrifuged at 3,000 rpm for 15 min and the supernatants 
were collected. The supernatants were used for measurement of 
scavenging enzyme activities and lipid peroxides (TBARS). 
 
 
Determination of fasting blood sugar 
 




Determination of biochemical parameters 
 
Thiobarbituric acid reactive substances (TBARS) 
 
Hepatic lipid peroxidation was determined as thiobarbituric acid 
reactive substances as described by Torres et al. (2004). Lipid 
peroxidation generates peroxide intermediates which upon 
cleavage release malondialdehyde, a product which react with 
thiobarbituric acid. The product of the reaction is a coloured 







 was used in the calculation of TBARS and 
values were expressed as nmol/mg protein. 
 
 
Aspartate aminotransferase (AST) 
 
Aspartate aminotransferase (AST) catalyzes the transamination of 
aspartate to alpha-ketoglutarate to form glutamate and 
oxaloacetate, which then reacts with 2,4-dinitro-phenylhydrazine to 
form hydrazone derivative of oxaloacetate, a coloured complex 
which can be measured at 546 nm. Aspartate aminotransferase 
was determined as described by Reitman and Frankel (1957) using 
assay kits (Agape Laboratories Ltd, UK). 
 
 
Alanine aminotransferase (ALT) 
 
Alanine aminotransferase (ALT) catalyzes the transamination of 
alanine to alpha-ketoglutarate to form glutamate and pyruvic acid, 
which then reacts with 2,4-dinitro-phenylhydrazine to form 
hydrazone derivative of pyruvate, a coloured complex which can be 
measured at 546 nm. Alanine aminotransferase was determined as 
described by Reitman and Frankel (1957) using assay kits (Agape 
Laboratories Ltd, UK). 
 
 
Alkaline phosphatase (ALP) 
 
Serum alkaline phosphatise was determined as described by Klein 
et al. (1960). Serum alkaline phosphatase catalyses the hydrolysis 
of a colourless substrate of phenolphthalein monophosphate giving 
rise to phosphoric acid and phenolphthalein which, at alkaline pH 
values turns into a pink colour that can be determined photo-
metrically at 550 nm. 






This was determined colorimetrically according to the method 
described by Jendrassic and Grof (1938) using assay kits (Agape 
Laboratories Ltd, UK). Conjugated bilirubin reacts with diazotized 
sulphanilic acid in alkaline medium to form a blue complex. Total 
bilirubin is determined in the presence of caffeine, which releases 




Assay of enzymatic antioxidant 
 
Superoxide dismutase (SOD) 
 
The activity of superoxide dismutase was measured at 560 nm 
according to the method described by Martin et al. (1987). Briefly, 
auto-oxidation of hematoxylin is inhibited by SOD at assay pH, the 
percentage of inhibition is linearly proportional to the amount of 






Catalase activity was measured using the method of Abei (1974). 
The decomposition rate of H2O2 was measured at 240 nm for 5 min 





was used to calculate the catalase activity and was 





All the values estimations were expressed as mean ± standard 
deviation and analyzed for ANOVA and post hoc Duncan’s -test 
using SPSS. Differences between groups were considered 
significant at P <0.05 levels. 
 
 
RESULTS AND DISCUSSION 
 
Thiobarbituric acid reactive substances (TBARS) 
levels 
 
TBARS level was significantly (p<0.05) elevated in the 
liver of diabetic control rats, when compared with the 
normal control rats. This increase was reduced 
significantly (p<0.05) in the extract treated rats as well as 
in the rats treated with glibenclamide (Table 1). 
 
 
Effects of the extract on hepatic enzymes 
 
Hepatic enzymes; alanine aminotransferase (ALT), 
aspartate aminotransferase (AST) and alkaline 
phosphatase (ALP) are shown in Table 2. Glibenclamide 
caused significant elevation (P<0.05) in the activities of 
these enzymes in the serum. Treatment with V. doniana 
aqueous extract at the dose of 100 mg/kg significantly 
reduced the activity of the enzymes compared to the 
control. Similarly, treatment with glibenclamide was able 
to reduce ALP activity significantly but non-significant in 




Table 1. TBARS levels in normal and diabetic rats treated with V. doniana aqueous, ethanol and n-hexane 
extract and glibenclamide. 
 
Treatment 
Tbars concentration (nmol/mg protein) 

































































N. control = Normal control; D. control = diabetic control; D. STD = diabetic standard drug (glibenclamide); D. AQ = 
diabetic aqueous extract; D. ETH = diabetic ethanol extract; D. HEX = diabetic hexane extract; N. AQ = non diabetic 




Table 2. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) 




Liver enzymes activity (U/L) 

































































N. control = normal control; D. control = diabetic control; D. STD = diabetic standard drug (glibenclamide); D. AQ = 
diabetic aqueous extract; D. ETH = diabetic ethanol extract; D. HEX = diabetic hexane extract; N. AQ = non diabetic 




ALT and AST. However, treatment of non-diabetic rats 
caused no significant decrease in the activity of the 
enzymes compared with the normal rats. 
 
 
Fasting blood sugar (FBS) 
 
Table 3 shows the levels of fasting blood sugar (FBS) in 
the animals. At day one (before induction), there was no 
statistical difference in the levels of FBS across the 
groups. At week two, there was significant (P<0.05) 
elevation of FBS in the diabetic groups compared to the 
normal groups. Treatment of diabetic animals with the 
extracts was able to restore FBS to normalcy across the 
week, with aqueous and ethanol extracts more effective 
than n-hexane and glibenclamide. 
Effects of the extract on enzymatic antioxidants 
 
A significant (p<0.05) decrease in catalase (CAT) and 
superoxide dismutase (SOD) activities were observed in 
the diabetic untreated rats compared to the normal rats 
(Tables 4 and 5). Treatment with the extract and 
glibenclamide showed a significant (p<0.05) increase in 
catalase activity, and glibenclamide treatment also 
significantly increased SOD activity but was non-
significant with extract treatment compared to the normal 
group. There was no significant increase in the activity of 
the enzymes in non-diabetic rats treated with the extract 
compared to the normal. 
 
 
Effects of the extract on serum bilirubin 
 
Administration of streptozotocin caused significant (P<0.05)








Fasting blood sugar (FBS) (mg/dl) 





































































































N. control = Normal control; D. control = diabetic control; D. STD = diabetic standard drug (glibenclamide); D. AQ = diabetic aqueous extract; D. 
ETH = diabetic ethanol extract; D. HEX = diabetic hexane extract; N. AQ = non diabetic aqueous extract; N. ETH = non diabetic ethanol extract; 
N. HEX = non diabetic hexane extract. Values are mean ± SD, n = 5. All treated groups are compared with control. Values with different 




Table 4. Catalase (CAT) activity in normal and diabetic rats treated with V. doniana aqueous, ethanol and n-
hexane extract and glibenclamide. 
 
Treatment 
Catalase  (CAT) activity (U/mg protein) 



































































elevation in serum total, direct and indirect bilirubin 
concentration in the control animals compared to normal 
(Table 6). Both extract and glibenclamide treatment 
caused significant reduction in bilirubin concentration in 
the experimental rats compared to normal. However, 
administration of extract to normal rat showed no 






Diabetes is currently considered as a vascular disease 
(Ibrahim and Rizk, 2008). It has also been considered by 
researchers that hyperglycaemia-induced oxidative stress 
is a critical pathogenic mechanism that initiates a 
plethora of cascade metabolic and vascular perturbations 
(Ibrahim and Rizk, 2008; Housom et al., 2001; Hunt et al., 
1988). Studies have revealed the beneficial effects of 
some secondary plant metabolites that possess antioxi-
dant activity in diabetes management. Lipid peroxidation 
was investigated in our study by assessing the hepatic 
levels of TBARS; a significant increase in TBARS levels 
of diabetic rats was observed when compared to normal 
control rats. Numerous studies with human and animal 
models have also shown increased lipid peroxidative 
status in membranes of different tissues in diabetes 
(Feillet-Coudray et al., 1999; Kakkar et al., 1998; Aydin et 
al., 2001; Obresova et al., 2003, Ugochukwu and 
Courbone, 2003). The extract produced significant 
decreases in TBARS levels in treated diabetic rats when 
compared to diabetic control rats. Treatment with 
glibenclamide also caused a slight decrease in TBARS 
levels of the treated rats. These reductions could lead to 
a decrease in oxidative stress and hence a reductions in 
the rate of progression of diabetic complications in the 
liver. Table 2 represents the changes in the activities of 
aspartate transaminase, alanine transaminase and 
alkaline phosphatase. 
In the assessment of liver damage by the determination 




Table 5. Superoxide dismutase (SOD) activity in normal and diabetic rats treated with V. doniana aqueous, 
ethanol and n-hexane extract and glibenclamide. 
 
Treatment 
Suproxide dismutase (SOD) activity (U/mg protein) 

































































N. control = Normal control; D. control = diabetic control; D. STD = diabetic standard drug (glibenclamide); D. AQ = 
diabetic aqueous extract; D. ETH = diabetic ethanol extract; D. HEX = diabetic hexane extract; N. AQ = non diabetic 
aqueous extract; N. ETH = non diabetic ethanol extract; N. HEX = non diabetic hexane extract. Values are mean ± SD, 
n = 5. All treated groups are compared with control. Values with different superscript across the group are statistically 
significant at P<0.05. 
 
 




Bilirubin (bil) concentration (mg/dl) 

































































N. control = Normal control; D. control = diabetic control; D. STD = diabetic standard drug (glibenclamide); D. AQ = 
diabetic aqueous extract; D. ETH = diabetic ethanol extract; D. HEX = diabetic hexane extract; N. AQ = non diabetic 
aqueous extract; N. ETH = non diabetic ethanol extract; N. HEX = non diabetic hexane extract. Values are mean ± SD, n 
= 5. All treated groups are compared with control. Values with different superscript across the group are statistically 




of enzyme, enzyme levels such as aspartate transami-
nase and alanine transaminase are largely used. 
Elevated levels of serum enzymes are indicative of 
cellular leakage and loss of functional integrity of cell 
membrane in liver (Watkins and Seef, 2006). Hepato-
cellular necrosis leads to high level of serum markers in 
the blood, among these, aspartate transminase, alanine 
transaminase represents 90% of total enzyme and high 
level of alanine transminase in the blood is a better index 
of liver injury, but the elevated levels of enzymes are 
decreased to normal levels after treatment with the 
extract. Alkaline phosphatase concentration is related to 
the functioning of hepatocytes, high level of alkaline 
phosphatase in the blood serum is related to the 
increased synthesis of it by cells lining bile canaliculi 
usually in response to cholestasis and increased biliary 
pressure (Handa and Sharma, 1990). Increased level 
was obtained owing to steptozotocin administration and it 
was brought to normal level by the extract treatment. 
Treatment with V. doniana aqueous leaf extract 
decreased the serum levels of aspartate transaminase, 
alanine transaminase and alkaline phosphatse towards 
the respective normal value; that is an indication of 
stabilization of plasma membrane as well as repair of 
hepatic tissue damage caused by STZ. The aforemen-
tioned changes can be considered as an expression of 
the functional improvement of hepatocytes, which may be 
caused by an accelerated regeneration of parenchymal 
cells. 





destruction and blockage of biliary tract. As a result of 
blockage of the biliary tract, there was mass inhibition of 
the conjugation reaction and release of unconjugated 
bilirubin from damaged and dead hepatocytes; this is in 
line with the report given by Gaw et al. (1999). 
Administration of extract decreased the level of bilirubin, 
suggesting that it offered protection. Catalase which has 
been known to scavenge and detoxify H2O2 showed a 
decreased activity in the diabetic control rats probably 
due to decreased concentration by H2O2 in the system 
(Esra et al., 2004).  
Treatment with the extract significantly (p>0.05) 
increased the activity in the treated rats indicating a 
possible attenuation of oxidant stress. SOD activity was 
observed to decrease in the diabetic rats compared to the 
normal control rats probably acting in a compensatory 
mechanism to maintain homeostasis. The increase in 
SOD activity may also be due to decreased mutation of 
superoxide anions due to their decreased production at 
the onset of diabetes. The diabetic rats treated with the 
extract showed increased SOD activity while treatment 
with glibenclamide demonstrated less increase in SOD 
activity. This suggests that the extract may have reduced 
the production of ROS with a concomitant increase in 
SOD activity. 
Our observations are in well agreement with the reports 
by several workers that STZ-induced diabetes mellitus 
and insulin deficiency leads to increased blood glucose 
(Chaude et al., 2001). It has been reported that STZ at 
lower doses (50 mg/ kg) produce partial destruction of 
pancreatic β-cells with permanent diabetes condition 
(Aybar et al., 2002) and there may be more possibility of 
many surviving β-cells (Cherian et al., 1992). Since a 
much low dose of STZ was chosen for this study, there 
may be many surviving β-cells, capable of undergoing 
regeneration. Prolonged administration of extract may 
stimulate the β-cells of islets of Langerhans to produce 
insulin (Cherian et al., 1992).  
The antihyperglycemic effect of the extracts was 
compared with glibenclamide, a standard hypoglycemic 
drug. Glibenclamide has long been used to treat 
diabetes, to stimulate insulin secretion from the pan-
creatic β-cells. From the results, it appears that still 
insulin producing β-cells are functioning in STZ treated 
diabetic rats and stimulation of insulin release could be 
responsible for most of the observed metabolic activities. 
Further, the observed blood glucose-lowering effect in 
fasted normal and STZ induced diabetic rats could 
possibly be due to the increased peripheral glucose 
utilization. A number of other plants have also been 
shown to exert hypoglycemic activity through stimulation 
of insulin release (Pari and Maheswari, 2000; Prince and 
Menon, 2000). 
Our results therefore indicate that the aqueous extract 
when used for diabetes management may control and or 
prevent the development of diabetic complications arising 
from increased oxidative stress and lipid peroxidation. 
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